How we know
Every link on this study, and who decided it
The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.
Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.
Nivolumab
From the registry record2 judgments on this linkAll judgments on this study
| When | Link | Judge | Decision | State |
|---|---|---|---|---|
| Oct 14 | The record itself | ClinicalTrials.gov record | Version of 2026-10-14 | Record change |
| Nov 2 | Nivolumab | Claude Opus 5.5 | Tested | Current |
| Nov 2 | Oxaliplatin | Claude Opus 5.5 | Background | Current |
| Nov 2 | Tegafur | Claude Opus 5.5 | Background | Current |
| Nov 2 | Gimeracil | Claude Opus 5.5 | Background | Current |
| Nov 2 | Oxonic Acid | Claude Opus 5.5 | Background | Current |
| Nov 2 | Capecitabine | Claude Opus 5.5 | Background | Current |
| Nov 2 | Bevacizumab | Claude Opus 5.5 | Background | Current |
| Nov 2 | Temozolomide | Claude Opus 5.5 | Background | Current |
| Nov 2 | Ipilimumab | Claude Opus 5.5 | Background · established | Current |
| Nov 2 | INT028061 | Claude Opus 5.5 | Background | Current |
| Nov 14 | Pan-tumor | Rule based · condition-kind rule | Not read | Current |
| Nov 18 | Nivolumab | Rule based · role rule | Tested | Agrees |
| Nov 18 | Oxaliplatin | Rule based · role rule | Background | Agrees |
| Nov 18 | Tegafur | Rule based · role rule | Background | Agrees |
| Nov 18 | Gimeracil | Rule based · role rule | Background | Agrees |
| Nov 18 | Oxonic Acid | Rule based · role rule | Background | Agrees |
| Nov 18 | Capecitabine | Rule based · role rule | Background | Agrees |
| Nov 18 | Bevacizumab | Rule based · role rule | Background | Agrees |
| Nov 18 | Temozolomide | Rule based · role rule | Background | Agrees |
| Nov 18 | Ipilimumab | Rule based · role rule | Background | Agrees |
| Nov 18 | INT028061 | Rule based · role rule | Background | Agrees |
The rules, in plain words
“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.
Which drugs a study tests
Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.
Where the whole record has been read, that reading's answer replaces the rule's.
How a condition link is counted
For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.
A decision on file for one study overrides it, with who made it and when.